nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—CYP2B6—malignant glioma	0.456	0.603	CbGaD
Ketamine—PTGS1—malignant glioma	0.3	0.397	CbGaD
Ketamine—GRIN1—telencephalic ventricle—malignant glioma	0.00888	0.0762	CbGeAlD
Ketamine—GRIN2B—telencephalic ventricle—malignant glioma	0.00847	0.0727	CbGeAlD
Ketamine—OPRM1—telencephalic ventricle—malignant glioma	0.0045	0.0386	CbGeAlD
Ketamine—DRD2—telencephalic ventricle—malignant glioma	0.003	0.0258	CbGeAlD
Ketamine—GRIN2C—brainstem—malignant glioma	0.0029	0.0249	CbGeAlD
Ketamine—GRIN2D—brainstem—malignant glioma	0.0027	0.0231	CbGeAlD
Ketamine—GRIN2C—telencephalon—malignant glioma	0.00257	0.0221	CbGeAlD
Ketamine—GRIN1—brainstem—malignant glioma	0.0024	0.0206	CbGeAlD
Ketamine—GRIN2D—telencephalon—malignant glioma	0.00239	0.0205	CbGeAlD
Ketamine—GRIN2B—brainstem—malignant glioma	0.00229	0.0197	CbGeAlD
Ketamine—GRIN3A—telencephalon—malignant glioma	0.00225	0.0193	CbGeAlD
Ketamine—TACR1—brainstem—malignant glioma	0.0022	0.0189	CbGeAlD
Ketamine—GRIN1—telencephalon—malignant glioma	0.00213	0.0183	CbGeAlD
Ketamine—GRIN2B—telencephalon—malignant glioma	0.00203	0.0175	CbGeAlD
Ketamine—GRIN2C—medulla oblongata—malignant glioma	0.00202	0.0173	CbGeAlD
Ketamine—GRIN2A—brainstem—malignant glioma	0.002	0.0172	CbGeAlD
Ketamine—TACR1—telencephalon—malignant glioma	0.00195	0.0167	CbGeAlD
Ketamine—GRIN2D—medulla oblongata—malignant glioma	0.00188	0.0161	CbGeAlD
Ketamine—GRIN2A—telencephalon—malignant glioma	0.00178	0.0153	CbGeAlD
Ketamine—GRIN2D—spinal cord—malignant glioma	0.00168	0.0144	CbGeAlD
Ketamine—OPRD1—telencephalon—malignant glioma	0.00158	0.0136	CbGeAlD
Ketamine—GRIN1—midbrain—malignant glioma	0.00153	0.0131	CbGeAlD
Ketamine—GRIN1—spinal cord—malignant glioma	0.00149	0.0128	CbGeAlD
Ketamine—GRIN2C—central nervous system—malignant glioma	0.00146	0.0125	CbGeAlD
Ketamine—GRIN2C—cerebellum—malignant glioma	0.00143	0.0123	CbGeAlD
Ketamine—GRIN2B—spinal cord—malignant glioma	0.00143	0.0122	CbGeAlD
Ketamine—GRIN2A—medulla oblongata—malignant glioma	0.0014	0.012	CbGeAlD
Ketamine—TACR1—spinal cord—malignant glioma	0.00137	0.0117	CbGeAlD
Ketamine—GRIN2D—central nervous system—malignant glioma	0.00136	0.0117	CbGeAlD
Ketamine—GRIN2D—cerebellum—malignant glioma	0.00133	0.0114	CbGeAlD
Ketamine—GRIN3A—central nervous system—malignant glioma	0.00128	0.011	CbGeAlD
Ketamine—GRIN2A—midbrain—malignant glioma	0.00128	0.011	CbGeAlD
Ketamine—GRIN2A—spinal cord—malignant glioma	0.00125	0.0107	CbGeAlD
Ketamine—OPRM1—brainstem—malignant glioma	0.00122	0.0104	CbGeAlD
Ketamine—GRIN1—central nervous system—malignant glioma	0.00121	0.0104	CbGeAlD
Ketamine—GRIN1—cerebellum—malignant glioma	0.00118	0.0102	CbGeAlD
Ketamine—PTGS1—endothelium—malignant glioma	0.00118	0.0101	CbGeAlD
Ketamine—GRIN2C—brain—malignant glioma	0.00116	0.00996	CbGeAlD
Ketamine—GRIN2B—central nervous system—malignant glioma	0.00116	0.00992	CbGeAlD
Ketamine—GRIN2B—cerebellum—malignant glioma	0.00113	0.0097	CbGeAlD
Ketamine—TACR1—central nervous system—malignant glioma	0.00111	0.00951	CbGeAlD
Ketamine—PTGS1—blood vessel—malignant glioma	0.00109	0.00932	CbGeAlD
Ketamine—OPRM1—telencephalon—malignant glioma	0.00108	0.00927	CbGeAlD
Ketamine—GRIN2D—brain—malignant glioma	0.00108	0.00926	CbGeAlD
Ketamine—GRIN3A—brain—malignant glioma	0.00101	0.00871	CbGeAlD
Ketamine—GRIN2A—central nervous system—malignant glioma	0.00101	0.00867	CbGeAlD
Ketamine—GRIN2A—cerebellum—malignant glioma	0.000988	0.00848	CbGeAlD
Ketamine—GRIN1—brain—malignant glioma	0.000962	0.00826	CbGeAlD
Ketamine—GRIN2B—brain—malignant glioma	0.000918	0.00788	CbGeAlD
Ketamine—OPRD1—central nervous system—malignant glioma	0.000901	0.00773	CbGeAlD
Ketamine—SLC6A2—brainstem—malignant glioma	0.000892	0.00765	CbGeAlD
Ketamine—TACR1—brain—malignant glioma	0.00088	0.00755	CbGeAlD
Ketamine—OPRK1—central nervous system—malignant glioma	0.000864	0.00741	CbGeAlD
Ketamine—OPRK1—cerebellum—malignant glioma	0.000844	0.00724	CbGeAlD
Ketamine—DRD2—brainstem—malignant glioma	0.000813	0.00697	CbGeAlD
Ketamine—GRIN2A—brain—malignant glioma	0.000802	0.00688	CbGeAlD
Ketamine—SLC6A2—telencephalon—malignant glioma	0.000791	0.00679	CbGeAlD
Ketamine—DRD2—retina—malignant glioma	0.000784	0.00673	CbGeAlD
Ketamine—OPRM1—midbrain—malignant glioma	0.000776	0.00666	CbGeAlD
Ketamine—OPRM1—spinal cord—malignant glioma	0.000757	0.0065	CbGeAlD
Ketamine—DRD2—telencephalon—malignant glioma	0.000721	0.00619	CbGeAlD
Ketamine—OPRD1—brain—malignant glioma	0.000715	0.00614	CbGeAlD
Ketamine—OPRK1—brain—malignant glioma	0.000686	0.00588	CbGeAlD
Ketamine—ABCB1—blood vessel—malignant glioma	0.000642	0.00551	CbGeAlD
Ketamine—SLC6A2—medulla oblongata—malignant glioma	0.000622	0.00534	CbGeAlD
Ketamine—OPRM1—central nervous system—malignant glioma	0.000614	0.00527	CbGeAlD
Ketamine—PTGS1—telencephalon—malignant glioma	0.000527	0.00452	CbGeAlD
Ketamine—DRD2—midbrain—malignant glioma	0.000518	0.00444	CbGeAlD
Ketamine—OPRM1—brain—malignant glioma	0.000488	0.00418	CbGeAlD
Ketamine—SLC6A2—central nervous system—malignant glioma	0.00045	0.00386	CbGeAlD
Ketamine—DRD2—central nervous system—malignant glioma	0.00041	0.00352	CbGeAlD
Ketamine—DRD2—cerebellum—malignant glioma	0.000401	0.00344	CbGeAlD
Ketamine—ABCB1—embryo—malignant glioma	0.000383	0.00329	CbGeAlD
Ketamine—PTGS1—spinal cord—malignant glioma	0.000369	0.00317	CbGeAlD
Ketamine—SLC6A2—brain—malignant glioma	0.000357	0.00306	CbGeAlD
Ketamine—ABCB1—retina—malignant glioma	0.000339	0.00291	CbGeAlD
Ketamine—CYP2B6—central nervous system—malignant glioma	0.000331	0.00284	CbGeAlD
Ketamine—DRD2—brain—malignant glioma	0.000325	0.00279	CbGeAlD
Ketamine—ABCB1—telencephalon—malignant glioma	0.000312	0.00267	CbGeAlD
Ketamine—PTGS1—central nervous system—malignant glioma	0.0003	0.00257	CbGeAlD
Ketamine—CYP2C8—brain—malignant glioma	0.000293	0.00252	CbGeAlD
Ketamine—CYP2B6—brain—malignant glioma	0.000263	0.00226	CbGeAlD
Ketamine—CYP3A4—central nervous system—malignant glioma	0.00025	0.00215	CbGeAlD
Ketamine—ABCB1—medulla oblongata—malignant glioma	0.000245	0.0021	CbGeAlD
Ketamine—PTGS1—brain—malignant glioma	0.000238	0.00204	CbGeAlD
Ketamine—ABCB1—midbrain—malignant glioma	0.000224	0.00192	CbGeAlD
Ketamine—ABCB1—spinal cord—malignant glioma	0.000218	0.00187	CbGeAlD
Ketamine—ABCB1—central nervous system—malignant glioma	0.000177	0.00152	CbGeAlD
Ketamine—ABCB1—cerebellum—malignant glioma	0.000173	0.00149	CbGeAlD
Ketamine—ABCB1—brain—malignant glioma	0.000141	0.00121	CbGeAlD
Ketamine—DRD2—Signaling Pathways—NTRK1—malignant glioma	1.08e-05	8.47e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PTPN11—malignant glioma	1.07e-05	8.44e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—KRAS—malignant glioma	1.07e-05	8.43e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PDGFB—malignant glioma	1.07e-05	8.41e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—FGFR1—malignant glioma	1.06e-05	8.36e-05	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.06e-05	8.35e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.05e-05	8.24e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—FGF2—malignant glioma	1.05e-05	8.24e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—HIF1A—malignant glioma	1.05e-05	8.24e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—PIK3CD—malignant glioma	1.04e-05	8.18e-05	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—PIK3CA—malignant glioma	1.03e-05	8.12e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—GSTP1—malignant glioma	1.03e-05	8.09e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—BRAF—malignant glioma	1.03e-05	8.07e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PTGS1—malignant glioma	1.03e-05	8.07e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—IDH2—malignant glioma	1.02e-05	8.04e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GSTT1—malignant glioma	1.02e-05	8.04e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.02e-05	8.04e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.01e-05	7.97e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CAV1—malignant glioma	1.01e-05	7.97e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—CAV1—malignant glioma	1.01e-05	7.94e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—KDR—malignant glioma	1e-05	7.88e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MMP3—malignant glioma	1e-05	7.88e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CAT—malignant glioma	1e-05	7.87e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—AKT2—malignant glioma	9.99e-06	7.86e-05	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TP53—malignant glioma	9.99e-06	7.86e-05	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—PIK3CB—malignant glioma	9.99e-06	7.86e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—EGFR—malignant glioma	9.95e-06	7.82e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CDKN2B—malignant glioma	9.93e-06	7.81e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—PIK3CA—malignant glioma	9.85e-06	7.74e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MDM2—malignant glioma	9.81e-06	7.71e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—RAF1—malignant glioma	9.78e-06	7.69e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—ERBB2—malignant glioma	9.67e-06	7.6e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	9.65e-06	7.59e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—F2—malignant glioma	9.65e-06	7.58e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PTK2—malignant glioma	9.65e-06	7.58e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—FN1—malignant glioma	9.65e-06	7.58e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP2B6—malignant glioma	9.62e-06	7.56e-05	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—CXCL8—malignant glioma	9.6e-06	7.55e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PIK3CD—malignant glioma	9.6e-06	7.55e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PTGS1—malignant glioma	9.59e-06	7.54e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	9.55e-06	7.51e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PIK3CB—malignant glioma	9.54e-06	7.5e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—BCHE—malignant glioma	9.54e-06	7.5e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—BAD—malignant glioma	9.53e-06	7.49e-05	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—PIK3CA—malignant glioma	9.51e-06	7.48e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HES1—malignant glioma	9.48e-06	7.45e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—NCOR1—malignant glioma	9.46e-06	7.43e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—NOTCH1—malignant glioma	9.44e-06	7.42e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—SLC5A5—malignant glioma	9.42e-06	7.41e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NCOR1—malignant glioma	9.42e-06	7.41e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—KRAS—malignant glioma	9.4e-06	7.39e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—RAF1—malignant glioma	9.29e-06	7.31e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CD80—malignant glioma	9.25e-06	7.27e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—APC—malignant glioma	9.23e-06	7.26e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PIK3CG—malignant glioma	9.23e-06	7.26e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PIK3CG—malignant glioma	9.2e-06	7.24e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—FGF2—malignant glioma	9.19e-06	7.23e-05	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—IL2—malignant glioma	9.18e-06	7.21e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CXCL8—malignant glioma	9.17e-06	7.21e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—EGF—malignant glioma	9.12e-06	7.17e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—PIK3CB—malignant glioma	9.07e-06	7.13e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PTPN11—malignant glioma	9.07e-06	7.13e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PDGFRA—malignant glioma	9.02e-06	7.09e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—BCHE—malignant glioma	8.91e-06	7.01e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PPARG—malignant glioma	8.88e-06	6.98e-05	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—AKT1—malignant glioma	8.86e-06	6.97e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.84e-06	6.95e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—SLC5A5—malignant glioma	8.8e-06	6.92e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—IDH1—malignant glioma	8.8e-06	6.92e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CASP3—malignant glioma	8.78e-06	6.9e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL2—malignant glioma	8.77e-06	6.89e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SPP1—malignant glioma	8.76e-06	6.89e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CXCL8—malignant glioma	8.72e-06	6.86e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GSTP1—malignant glioma	8.71e-06	6.85e-05	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	8.68e-06	6.82e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—BRAF—malignant glioma	8.68e-06	6.82e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—PIK3CA—malignant glioma	8.64e-06	6.79e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MDM2—malignant glioma	8.6e-06	6.76e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—RAF1—malignant glioma	8.57e-06	6.74e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SPHK1—malignant glioma	8.51e-06	6.69e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—ERBB2—malignant glioma	8.48e-06	6.67e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CAT—malignant glioma	8.48e-06	6.66e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—AKT2—malignant glioma	8.45e-06	6.64e-05	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—AKT1—malignant glioma	8.44e-06	6.63e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—EGFR—malignant glioma	8.41e-06	6.61e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PIK3CB—malignant glioma	8.37e-06	6.58e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP2C18—malignant glioma	8.34e-06	6.56e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL2—malignant glioma	8.33e-06	6.55e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.32e-06	6.54e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TERT—malignant glioma	8.3e-06	6.53e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MMP9—malignant glioma	8.3e-06	6.52e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.25e-06	6.48e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PTEN—malignant glioma	8.25e-06	6.48e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PIK3CD—malignant glioma	8.11e-06	6.38e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PDGFB—malignant glioma	8.1e-06	6.37e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PIK3CD—malignant glioma	8.09e-06	6.36e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—FGFR1—malignant glioma	8.06e-06	6.34e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—AKT1—malignant glioma	8.05e-06	6.33e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CXCL8—malignant glioma	8.04e-06	6.32e-05	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—PIK3CA—malignant glioma	8.04e-06	6.32e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—NCOR1—malignant glioma	8.01e-06	6.29e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—KRAS—malignant glioma	7.94e-06	6.25e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HIF1A—malignant glioma	7.94e-06	6.24e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—FGF2—malignant glioma	7.77e-06	6.11e-05	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—AKT1—malignant glioma	7.77e-06	6.11e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CAV1—malignant glioma	7.71e-06	6.06e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CASP3—malignant glioma	7.7e-06	6.05e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL2—malignant glioma	7.69e-06	6.04e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CAV1—malignant glioma	7.68e-06	6.04e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—KDR—malignant glioma	7.59e-06	5.97e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GSTP1—malignant glioma	7.59e-06	5.97e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—VEGFA—malignant glioma	7.45e-06	5.86e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CAT—malignant glioma	7.39e-06	5.81e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—STAT3—malignant glioma	7.38e-06	5.8e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—F2—malignant glioma	7.31e-06	5.75e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—FN1—malignant glioma	7.31e-06	5.75e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—PIK3CA—malignant glioma	7.3e-06	5.74e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MMP9—malignant glioma	7.27e-06	5.72e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MDM2—malignant glioma	7.27e-06	5.72e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—RAF1—malignant glioma	7.24e-06	5.7e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PTEN—malignant glioma	7.23e-06	5.69e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—BAD—malignant glioma	7.22e-06	5.68e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.19e-06	5.66e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—ERBB2—malignant glioma	7.17e-06	5.63e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NOTCH1—malignant glioma	7.15e-06	5.62e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GSTP1—malignant glioma	7.09e-06	5.57e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PIK3CB—malignant glioma	7.07e-06	5.56e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—AKT1—malignant glioma	7.06e-06	5.55e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PIK3CB—malignant glioma	7.05e-06	5.54e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3CG—malignant glioma	7.02e-06	5.52e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CD80—malignant glioma	7.01e-06	5.51e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—APC—malignant glioma	7e-06	5.5e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3CG—malignant glioma	7e-06	5.5e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PTGS2—malignant glioma	6.99e-06	5.49e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—NCOR1—malignant glioma	6.97e-06	5.48e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—EGF—malignant glioma	6.92e-06	5.44e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CAT—malignant glioma	6.9e-06	5.42e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PTPN11—malignant glioma	6.87e-06	5.4e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MYC—malignant glioma	6.85e-06	5.39e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CXCL8—malignant glioma	6.8e-06	5.34e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PPARG—malignant glioma	6.78e-06	5.33e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GSTT1—malignant glioma	6.75e-06	5.3e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—EGFR—malignant glioma	6.7e-06	5.27e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—BRAF—malignant glioma	6.58e-06	5.17e-05	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—AKT1—malignant glioma	6.57e-06	5.16e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—VEGFA—malignant glioma	6.53e-06	5.14e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CAV1—malignant glioma	6.53e-06	5.13e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—NCOR1—malignant glioma	6.52e-06	5.12e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CASP3—malignant glioma	6.51e-06	5.11e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL2—malignant glioma	6.5e-06	5.11e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—STAT3—malignant glioma	6.47e-06	5.08e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AKT2—malignant glioma	6.4e-06	5.03e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—EGFR—malignant glioma	6.37e-06	5.01e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—KRAS—malignant glioma	6.33e-06	4.98e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PTGS1—malignant glioma	6.32e-06	4.97e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.24e-06	4.9e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3CD—malignant glioma	6.17e-06	4.85e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3CD—malignant glioma	6.15e-06	4.83e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MMP9—malignant glioma	6.15e-06	4.83e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PTEN—malignant glioma	6.11e-06	4.81e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PTEN—malignant glioma	6.09e-06	4.79e-05	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—PIK3CA—malignant glioma	6.09e-06	4.79e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—KRAS—malignant glioma	6.02e-06	4.73e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MYC—malignant glioma	6.01e-06	4.72e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—AKT1—malignant glioma	5.96e-06	4.69e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3CG—malignant glioma	5.94e-06	4.67e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—FGF2—malignant glioma	5.89e-06	4.63e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—EGFR—malignant glioma	5.88e-06	4.62e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—BCHE—malignant glioma	5.88e-06	4.62e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PIK3CA—malignant glioma	5.82e-06	4.57e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SLC5A5—malignant glioma	5.81e-06	4.56e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PPARG—malignant glioma	5.74e-06	4.51e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CAV1—malignant glioma	5.69e-06	4.47e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TP53—malignant glioma	5.63e-06	4.43e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—KRAS—malignant glioma	5.55e-06	4.37e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—PIK3CA—malignant glioma	5.53e-06	4.35e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—VEGFA—malignant glioma	5.52e-06	4.34e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MDM2—malignant glioma	5.51e-06	4.33e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—RAF1—malignant glioma	5.49e-06	4.32e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—STAT3—malignant glioma	5.47e-06	4.3e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ERBB2—malignant glioma	5.43e-06	4.27e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3CB—malignant glioma	5.38e-06	4.23e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3CB—malignant glioma	5.36e-06	4.21e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PTGS2—malignant glioma	5.33e-06	4.19e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CAV1—malignant glioma	5.31e-06	4.18e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3CD—malignant glioma	5.23e-06	4.11e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3CG—malignant glioma	5.18e-06	4.07e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CXCL8—malignant glioma	5.15e-06	4.05e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PIK3CA—malignant glioma	5.1e-06	4.01e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MYC—malignant glioma	5.08e-06	3.99e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.07e-06	3.99e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PPARG—malignant glioma	5e-06	3.93e-05	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—AKT1—malignant glioma	4.98e-06	3.91e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—EGFR—malignant glioma	4.97e-06	3.91e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TP53—malignant glioma	4.94e-06	3.88e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CASP3—malignant glioma	4.93e-06	3.88e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL2—malignant glioma	4.92e-06	3.87e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3CG—malignant glioma	4.84e-06	3.8e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—AKT1—malignant glioma	4.75e-06	3.74e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—KRAS—malignant glioma	4.69e-06	3.69e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GSTP1—malignant glioma	4.68e-06	3.68e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PPARG—malignant glioma	4.67e-06	3.67e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MMP9—malignant glioma	4.66e-06	3.66e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PTEN—malignant glioma	4.65e-06	3.66e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PTEN—malignant glioma	4.63e-06	3.64e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3CB—malignant glioma	4.56e-06	3.58e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3CD—malignant glioma	4.55e-06	3.58e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CAT—malignant glioma	4.55e-06	3.58e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—AKT1—malignant glioma	4.52e-06	3.55e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PTGS2—malignant glioma	4.51e-06	3.55e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PIK3CA—malignant glioma	4.31e-06	3.39e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PIK3CA—malignant glioma	4.3e-06	3.38e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NCOR1—malignant glioma	4.3e-06	3.38e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3CD—malignant glioma	4.25e-06	3.34e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—VEGFA—malignant glioma	4.18e-06	3.29e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TP53—malignant glioma	4.17e-06	3.28e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—AKT1—malignant glioma	4.17e-06	3.28e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—STAT3—malignant glioma	4.14e-06	3.26e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3CB—malignant glioma	3.97e-06	3.12e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PTEN—malignant glioma	3.94e-06	3.09e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PTGS2—malignant glioma	3.93e-06	3.09e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MYC—malignant glioma	3.85e-06	3.03e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—EGFR—malignant glioma	3.77e-06	2.96e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3CB—malignant glioma	3.71e-06	2.91e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PTGS2—malignant glioma	3.67e-06	2.89e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—KRAS—malignant glioma	3.56e-06	2.8e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—AKT1—malignant glioma	3.52e-06	2.77e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—AKT1—malignant glioma	3.51e-06	2.76e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CAV1—malignant glioma	3.5e-06	2.75e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PTEN—malignant glioma	3.43e-06	2.7e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3CA—malignant glioma	3.28e-06	2.58e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3CA—malignant glioma	3.27e-06	2.57e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PTEN—malignant glioma	3.2e-06	2.52e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.19e-06	2.51e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TP53—malignant glioma	3.16e-06	2.49e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PPARG—malignant glioma	3.08e-06	2.42e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.8e-06	2.21e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3CA—malignant glioma	2.78e-06	2.18e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—AKT1—malignant glioma	2.68e-06	2.11e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AKT1—malignant glioma	2.67e-06	2.1e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.44e-06	1.92e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PTGS2—malignant glioma	2.42e-06	1.9e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3CA—malignant glioma	2.42e-06	1.9e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—AKT1—malignant glioma	2.27e-06	1.78e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3CA—malignant glioma	2.26e-06	1.78e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PTEN—malignant glioma	2.11e-06	1.66e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—AKT1—malignant glioma	1.98e-06	1.55e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—AKT1—malignant glioma	1.85e-06	1.45e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.49e-06	1.17e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—AKT1—malignant glioma	1.22e-06	9.57e-06	CbGpPWpGaD
